Works matching AU Green, Jennifer

Results: 367
    1
    2
    3
    4

    COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics Open Access.

    Published in:
    Nephrology Dialysis Transplantation, 2025, v. 40, n. 8, p. 1559, doi. 10.1093/ndt/gfaf022
    By:
    • Agarwal, Rajiv;
    • Green, Jennifer B;
    • Heerspink, Hiddo J L;
    • Mann, Johannes F E;
    • McGill, Janet B;
    • Mottl, Amy K;
    • Rosenstock, Julio;
    • Rossing, Peter;
    • Vaduganathan, Muthiah;
    • Brinker, Meike;
    • Edfors, Robert;
    • Li, Na;
    • Scheerer, Markus F;
    • Scott, Charlie;
    • Nangaku, Masaomi;
    • investigators, for the CONFIDENCE
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop.

    Published in:
    Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01993-3
    By:
    • Ceriello, Antonio;
    • Rodbard, Helena W.;
    • Battelino, Tadej;
    • Brosius, Frank;
    • Cosentino, Francesco;
    • Green, Jennifer;
    • Ji, Linong;
    • Kellerer, Monika;
    • Koob, Susan;
    • Kosiborod, Mikhail;
    • Lalic, Nebojsa;
    • Marx, Nikolaus;
    • Nedungadi, T. Prashant;
    • Parkin, Christopher G.;
    • Rydén, Lars;
    • Sheu, Wayne Huey-Herng;
    • Standl, Eberhard;
    • Vandvik, Per Olav;
    • Schnell, Oliver
    Publication type:
    Article
    30

    CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.

    Published in:
    Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01788-6
    By:
    • Schnell, Oliver;
    • Battelino, Tadej;
    • Bergenstal, Richard;
    • Birkenfeld, Andreas L.;
    • Ceriello, Antonio;
    • Cheng, Alice;
    • Davies, Melanie;
    • Edelman, Steve;
    • Forst, Thomas;
    • Giorgino, Francesco;
    • Green, Jennifer;
    • Groop, Per-Henrik;
    • Hadjadj, Samy;
    • J.L.Heerspink, Hiddo;
    • Hompesch, Marcus;
    • Izthak, Baruch;
    • Ji, Linong;
    • Kanumilli, Naresh;
    • Mankovsky, Boris;
    • Mathieu, Chantal
    Publication type:
    Article
    31
    32
    33
    34

    Creating Synergies for Change.

    Published in:
    Teachers College Record, 2019, v. 121, n. 12, p. 1, doi. 10.1177/016146811912101204
    By:
    • Carney, Joanne;
    • Chu, Marilyn;
    • Green, Jennifer;
    • Nutting, William;
    • Donnelly, Susan;
    • Clancy, Andrea;
    • Buly, Marsha Riddle;
    • Carroll, David
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41

    The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial Open Access.

    Published in:
    Nephrology Dialysis Transplantation, 2025, v. 40, n. 6, p. 1175, doi. 10.1093/ndt/gfae263
    By:
    • Judge, Parminder K;
    • Tuttle, Katherine R;
    • Staplin, Natalie;
    • Hauske, Sibylle J;
    • Zhu, Doreen;
    • Sardell, Rebecca;
    • Cronin, Lisa;
    • Green, Jennifer B;
    • Agrawal, Nikita;
    • Arimoto, Ryoki;
    • Mayne, Kaitlin J;
    • Sammons, Emily;
    • Brueckmann, Martina;
    • Shah, Shimoli V;
    • Rossing, Peter;
    • Nangaku, Masaomi;
    • Landray, Martin J;
    • Wanner, Christoph;
    • Baigent, Colin;
    • Haynes, Richard
    Publication type:
    Article
    42

    Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.

    Published in:
    Nephrology Dialysis Transplantation, 2025, v. 40, n. 4, p. 720, doi. 10.1093/ndt/gfae203
    By:
    • Mayne, Kaitlin J;
    • Sardell, Rebecca J;
    • Staplin, Natalie;
    • Judge, Parminder K;
    • Zhu, Doreen;
    • Sammons, Emily;
    • Cherney, David Z I;
    • Green, Jennifer B;
    • Levin, Adeera;
    • Pontremoli, Roberto;
    • Hauske, Sibylle J;
    • Emberson, Jonathan;
    • Preiss, David;
    • Landray, Martin J;
    • Baigent, Colin;
    • Wanner, Christoph;
    • Haynes, Richard;
    • Herrington, William G;
    • Group, the EMPA-KIDNEY Collaborative
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Hematologic Complications of Immune Checkpoint Inhibitors.

    Published in:
    Oncologist, 2019, v. 24, n. 5, p. 584, doi. 10.1634/theoncologist.2018-0574
    By:
    • Davis, Elizabeth J.;
    • Salem, Joe‐Elie;
    • Young, Arissa;
    • Green, Jennifer R.;
    • Ferrell, P. Brent;
    • Ancell, Kristin K.;
    • Lebrun‐Vignes, Benedicte;
    • Moslehi, Javid J.;
    • Johnson, Douglas B.
    Publication type:
    Article
    50